Biostime Inc., a leading name in the health and nutrition sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 1999, the company has established itself as a pioneer in the production of premium infant formula and probiotics, focusing on the nutritional needs of children and families. Biostime's core offerings include organic infant formula and advanced probiotic supplements, distinguished by their commitment to quality and innovation. The company has achieved significant milestones, including numerous awards for product excellence and safety standards, solidifying its position in the competitive market. With a strong emphasis on research and development, Biostime continues to enhance its product line, catering to the evolving demands of health-conscious consumers.
How does Biostime Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Dairy Processing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Biostime Inc.'s score of 50 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Biostime Inc., headquartered in China (CN), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Health and Happiness (H&H) International Holdings Limited, which may influence its climate commitments and performance metrics. While Biostime Inc. has not established its own reduction targets or climate pledges, it is important to note that any potential initiatives or targets may be cascaded from its parent company, H&H International Holdings Limited. This relationship suggests that Biostime may align with broader corporate sustainability goals set by H&H, although specific details on these initiatives are not provided. In the absence of direct emissions data and reduction targets, Biostime Inc.'s climate commitments remain unclear. The company may benefit from adopting industry-standard practices and targets to enhance its sustainability profile in the future.
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 15,115,000 | 0,000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 12,220,000 | 0,000,000 | 000,000 | 0,000,000 | - | - | 0,000,000 | 0,000,000 |
| Scope 3 | 2,226,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Biostime Inc.'s Scope 3 emissions, which decreased by 4% last year and increased significantly since 2017, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 82% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Biostime Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.